OpenLB
Open Library of Bioscience
Advanced Search
Cancers
Jan 15, 2021;13 (2):

Immune Therapies for Hematologic Malignancies.

Matthew J Olnes
Author Information
  1. Matthew J Olnes: Hematology and Medical Oncology, Alaska Native Tribal Health Consortium, 3900 Ambassador Dr., Anchorage, AK 99508, USA. ORCID
PMID: 33467389 DOI: 10.3390/cancers13020295

Abstract

The era of immunotherapy for hematologic malignancies began with the first allogeneic hematopoietic stem cell transplant (HSCT) study published by E [...].

References

  1. J Clin Oncol. 2018 May 10;36(14):1428-1439 [PMID: 29584546]
  2. N Engl J Med. 2018 Feb 8;378(6):518-528 [PMID: 29231133]
  3. N Engl J Med. 2020 Oct 22;383(17):1613-1623 [PMID: 33085860]
  4. Front Oncol. 2020 Jan 22;9:1380 [PMID: 32038992]
  5. J Clin Oncol. 2020 Mar 10;38(8):775-783 [PMID: 31895611]
  6. N Engl J Med. 2020 Feb 6;382(6):545-553 [PMID: 32023374]
  7. Lancet. 2017 Aug 5;390(10094):555-566 [PMID: 28600132]
  8. Lancet Oncol. 2020 Jul;21(7):978-988 [PMID: 32511983]
  9. Curr Hematol Malig Rep. 2018 Aug;13(4):244-255 [PMID: 29934935]
  10. N Engl J Med. 2019 May 2;380(18):1726-1737 [PMID: 31042825]
  11. N Engl J Med. 2015 Aug 13;373(7):621-31 [PMID: 26035255]
  12. J Clin Oncol. 2016 Mar 20;34(9):972-9 [PMID: 26811524]
  13. Nat Rev Clin Oncol. 2021 Feb;18(2):85-100 [PMID: 32934330]
  14. N Engl J Med. 2017 Mar 2;376(9):836-847 [PMID: 28249141]
  15. Int J Hematol. 2018 Mar;107(3):262-270 [PMID: 29383623]
  16. Front Immunol. 2019 Nov 27;10:2769 [PMID: 31827475]
  17. Haematologica. 2020 Jan;105(1):102-111 [PMID: 31004015]
  18. Blood. 2017 Dec 21;130(25):2709-2717 [PMID: 28974506]
  19. N Engl J Med. 2018 Jan 25;378(4):331-344 [PMID: 29224502]
  20. Nat Rev Clin Oncol. 2021 Feb;18(2):71-84 [PMID: 32978608]
  21. Nat Rev Drug Discov. 2020 Mar;19(3):200-218 [PMID: 31907401]
  22. Nat Rev Drug Discov. 2017 May;16(5):315-337 [PMID: 28303026]
  23. Lancet. 2015 May 9;385(9980):1853-62 [PMID: 25796459]
  24. Mol Cancer Ther. 2012 Dec;11(12):2674-84 [PMID: 23075808]
  25. Biol Blood Marrow Transplant. 2019 Dec;25(12):2305-2321 [PMID: 31446199]
  26. N Engl J Med. 2016 Aug 25;375(8):754-66 [PMID: 27557302]
  27. Leuk Lymphoma. 2018 Apr;59(4):790-802 [PMID: 28679300]
  28. Science. 2018 Mar 23;359(6382):1361-1365 [PMID: 29567707]
  29. Biol Blood Marrow Transplant. 2016 Jan;22(1):23-6 [PMID: 26551633]
  30. Lancet. 2019 Dec 7;394(10214):2096-2107 [PMID: 31735560]
  31. Sci Transl Med. 2019 Mar 27;11(485): [PMID: 30918115]
  32. Lancet. 2019 Jan 19;393(10168):229-240 [PMID: 30522922]
  33. Blood. 2019 Jul 4;134(1):22-29 [PMID: 30952672]
  34. Lancet Oncol. 2020 Feb;21(2):207-221 [PMID: 31859245]
  35. Blood Adv. 2019 Apr 9;3(7):980-983 [PMID: 30936058]
  36. JAMA. 2011 Feb 23;305(8):814-9 [PMID: 21343581]
  37. Nat Rev Clin Oncol. 2020 Mar;17(3):147-167 [PMID: 31848460]
  38. Nat Immunol. 2020 Aug;21(8):835-847 [PMID: 32690952]
  39. N Engl J Med. 2018 Nov 8;379(19):1811-1822 [PMID: 30403938]
  40. Cancers (Basel). 2019 Sep 12;11(9): [PMID: 31547472]
  41. Nat Rev Clin Oncol. 2017 Apr;14(4):203-220 [PMID: 27805626]
  42. N Engl J Med. 2016 Oct 6;375(14):1319-1331 [PMID: 27705267]
  43. J Clin Oncol. 2020 Jan 10;38(2):155-165 [PMID: 31693429]
  44. J Clin Oncol. 2020 Feb 20;38(6):623-632 [PMID: 31851556]
  45. Blood. 2019 Oct 3;134(14):1144-1153 [PMID: 31409671]
  46. J Clin Oncol. 2020 Nov 10;38(32):3794-3804 [PMID: 32701411]
  47. J Clin Oncol. 2020 Nov 10;38(32):3805-3815 [PMID: 33021872]
  48. N Engl J Med. 2015 Jan 22;372(4):311-9 [PMID: 25482239]
  49. Blood. 2020 Mar 5;135(10):713-723 [PMID: 31951650]
  50. N Engl J Med. 2020 Apr 2;382(14):1331-1342 [PMID: 32242358]
  51. N Engl J Med. 1957 Sep 12;257(11):491-6 [PMID: 13464965]
Editorial

Word Cloud

Created with Highcharts 10.0.0eraimmunotherapyhematologicmalignanciesbeganfirstallogeneichematopoieticstemcelltransplantHSCTstudypublishedE[]ImmuneTherapiesHematologicMalignancies

Similar Articles

Cited By